The promise of precision medicine starts with the sample data value chain.
Sample Data Value Chain: From Site to Result
This value chain was the focus of an exciting session at the 2025 SCOPE Summit for Clinical Operations Executives, where biospecimen operations, biomarker operations, and clinical operations teams shared how sample management practices lead directly to increased quality, speed, and reproducibility of research and development.
This year’s SCOPE conference stood out in a few notable ways:
- In an industry first, biopharma sponsors joined forces to pursue standardized and interoperable systems, processes, and ecosystems for connecting the sample data value chain.
- More data scientsts and leaders of IT functions attended the conference than ever, indicating that technology and data is playing and will play a key role for the future of clinical and sample operations.
QuartzBio’s Tobi Guennel, PhD, inspired lively discussion in his presentation, “From Site to Result: Real-Time Sample Intelligence Unlocked with GenAI.”
He explored the opportunities for technology to empower the people and processes across the entire sample data value chain, addressing:
- The importance of the sample data value chain within the Precision Medicine Value Chain
- Benefits of connecting data across the entire sample data value chain instead of focusing on individual links of the chain
- How a platform approach, leveraging a domain-specific Precision Medicine AI Agent Network, enables seamless data ingestion and real-time sample intelligence across the value chain
Watch the recording of our presentation*:
*Video not showing? Please accept cookies or view video here.
